Pomalyst (Celgene Corporation)
Welcome to the PulseAid listing for the Pomalyst drug offered from Celgene Corporation. This Thalidomide Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Celgene Corporation |
| NON-PROPRIETARY NAME: | pomalidomide |
| SUBSTANCE NAME: | POMALIDOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Thalidomide Analog [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-02-18 |
| END MARKETING DATE: | 0000-00-00 |
Pomalyst HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pomalyst from Celgene Corporation |
| LABELER NAME: | Celgene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2013-02-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59572-501_3c66b053-0cf9-4404-9ab4-301867433b8e |
| PRODUCT NDC: | 59572-501 |
| APPLICATION NUMBER: | NDA204026 |
Other POMALIDOMIDE Pharmaceutical Manufacturers / Labelers:
